In a recent decision by a Florida federal judge, Abilify maker Otsuka Pharmaceuticals was absolved of responsibility to preserve company e-mails that might have served as evidence for plaintiffs…

Last year, Otsuka Pharmaceutical Company filed…

Japan-based Otsuka Pharmaceuticals and its US partner, Bristol-Meyer Squibb, have settled three Abilify lawsuits that were scheduled to go to trial this summer. The plaintiffs, who suffer from…

Despite demonstrated dangers and side effects, which are the primary cause of action in the dozens of lawsuits currently part of a mass tort action, the atypical antipsychotic medication Abilify…

A recent article in the Canadian Journal of Psychiatry highlights a disturbing trend: the…

If “three strikes” laws applied to corporate “people” as they do to natural humans, Bristol-Myers Squibb (BMS) would be spending the rest of its life behind bars. Unfortunately, as we have seen,…

Award winning personal injury attorney Troy Rafferty, a shareholder with the Levin Papantonio Law Firm, has been appointed to the leadership team handling cases related to the Abilify (…

In May of 2016, the FDA finally issued a warning about the antidepressant medication aripiprizole, sold under the brand name Abilify as well as in generic form. That warning stated that use of…

The latest drug with harmful side effects now being targeted in litigation is an anti-psychotic medication known as aripiprazole, sold under the brand name Abilify as well as in generic…